With a $93 million settlement, Pfizer can wash its hands of more than a decade's worth of antitrust litigation over the once-lucrative cholesterol med Lipitor. For years, Pfizer and Sun Pharma’s ...

When it was in development, the cholesterol-lowering medicine was viewed as such an also-ran it almost didn't make it into patient testing. By the time Lipitor went on sale in early 1997, it was the ...

Drug prices almost always fall after a manufacturer’s patent expires and generics hit the market. But with its blockbuster cholesterol-fighting drug Lipitor going off-patent this week, drug maker ...

lower cholesterol levels in adults and some children reduce the risk of heart and blood vessel problems caused by high cholesterol, such as heart attack and stroke, in adults reduce the need for ...

NEW YORK (Reuters) - Pfizer Inc is interested in selling a non-prescription version of its Lipitor cholesterol drug after it loses U.S. patent protection, but would likely face a battle with ...